Patients undergoing lumbar fusion surgery lumber surgery
Conditions
Interventions
In the QLBi group, QLBi will be performed bilaterally under ultrasound guidance. The medication used will be 0.25% ropivacaine 0.4 mL/kg per side (0.8 mL/kg per side, maximum 60 mL). Pain management w
Nerve Block
intramuscular quadratus lumborum block (QLBi)
Sponsors
Yoshida Keisuke
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who meet all of the following criteria will be included. 1. Patients scheduled to undergo spinal fusion surgery at Th12 to L5 2. ASA-PS (American Society of Anesthesiologists) classification 1 to 2 at the time of consent 3. Informed consent for this study was obtained during the preoperative outpatient visit 4. Age 18 or older at the time of consent
Exclusion criteria
Exclusion criteria: Patients who meet any of the following criteria will be excluded from the study. 1) Patients who are expected to be unable to answer the NRS after surgery due to severe dementia or aftereffects of cerebral infarction, or who are unable to understand how to use IV-PCA 2) Patients with a history of hypersensitivity to ropivacaine or amide-type local anesthetics 3) Patients who have been receiving opioids since before surgery 4) Patients with reduced renal function with an estimated glomerular filtration rate (eGFR) of less than 30 ml/min/1.73 m2 since before surgery 5) Patients who are otherwise deemed ineligible by the anesthesiologist in charge
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Morphine usage within 24 hours after returning to the ward | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Time from returning to the room to first administration of acetaminophen 2) NRS at rest (immediately after returning to the room, 1, 3, 6, and 24 hours after returning to the room) 3) PONV incidence within 24 hours after returning to the room 4) Patient satisfaction 5) Presence or absence of delirium within 24 hours after returning to the room | — |
Contacts
Public ContactKeisuke Yoshida
Fukushima Medical University Hospital
Outcome results
None listed